GEODE CAPITAL MANAGEMENT, LLC
Position in ATNM — Actinium Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in ATNM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$318,445
-$15,947 QoQ
Shares Held
324,945
-3.3% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 47 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATNM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. ATNM ranks #381 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ATNM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $318,445 | 324,945 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $334,392 | 336,073 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $447,431 | 328,994 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $525,470 | 328,419 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $461,564 | 329,689 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,145,998 | 711,801 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $866,694 | 687,853 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,289,967 | 686,153 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,930,693 | 666,310 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $4,664,487 | 595,720 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,893,308 | 569,549 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,211,238 | 542,439 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,868,647 | 521,381 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,196,482 | 232,432 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,467,455 | 231,686 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,580,545 | 214,166 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $828,363 | 172,217 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $854,248 | 167,172 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,004,703 | 167,172 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,481,143 | 167,172 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,207,682 | 152,678 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $760,521 | 99,806 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $778,486 | 99,806 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $967,120 | 99,806 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $919,915 | 2,613,395 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $117,057 | 603,389 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||